|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, SAMHSA
|
CSR, FIC, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIEHS, NIGMS, NIMH, NIMHD, NLM, OD/DPCPSI/ODP, OD/DPCPSI/ODS
|
The Tobacco and Nicotine Research Interest Group (TANRIG) was formed in January 2003 with the goal of increasing collaboration, coordination, and communication of tobacco- and nicotine-related research among National Institutes of Health Institutes and Centers, and with partnering US Department of Health and Human Services agencies. Membership is limited to employees of the federal government. TANRIG is made up of nearly 175 members, many of whom have been involved since the initiation of the group in 2003.
|
|
Tobacco Longitudinal Mortality Study (TLMS) Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NCI, NHGRI, NIA
|
The Steering Committee oversees the operation and coordinates the research efforts of the TLMS study
|
|
Tobacco Product Disease Risks
|
Research Initiative
|
FDA
|
NCI
|
The NCI and the FDA-Center for Tobacco Products, in collaboration with the US Census Bureau, co-lead this study, which harmonizes data on cigarette, cigar, and pipe use from various Tobacco Use Supplements that have been administered over the years as part of the Current Population Survey. The participants in these surveys have been followed for mortality by linkage to the National Death Index. These data are used to provide contemporary estimates of the mortality risks of daily and non-daily use of cigarettes, pipes, and cigars.
|
|
Tobacco Regulatory Science Program
|
Research Initiative
|
FDA
|
NCI, NHLBI, NIDA, NIEHS, OD/DPCPSI/ODP
|
Located in the National Institutes of Health (NIH) Office of Disease Prevention, the Tobacco Regulatory Science Program (TRSP) coordinates the trans-NIH collaborative effort with the US Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) to conduct research to support its regulatory activities over tobacco products. Within the framework of the Tobacco Control Act, the NIH and FDA formed an interagency partnership to foster tobacco regulatory research. The NIH has the infrastructure for the solicitation, review, and management of research. The FDA has expertise in tobacco regulatory science and the authority and resources to support research responsive to FDA’s regulatory authority. Support from FDA was used to fund grants and to provide administrative support and oversight to manage Funding Opportunity Announcements (FOA), application review, policy implementation and oversight, and communicating and reporting to a variety of sources. (language updated by ODP TRSP) The Tobacco Regulatory Science Program (TRSP) is an interagency partnership between the National Institutes of Health and the Food and Drug Administration (FDA) Center for Tobacco Products to foster tobacco regulatory research. With funds from the FDA, NIH can provide new funding opportunities in tobacco regulatory science that complement existing NIH tobacco research activities. TRSP awards R01, K01, K99/R00, and U54s. Activities include research awards, annual meetings, manufacture and distribution of nicotine research cigarettes, online resources, and data sharing.
|
|
Tobacco Regulatory Science Program (TRSP)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
CSR, NCI
|
With the passage of the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), the FDA acquired the authority to regulate the manufacture, marketing, and distribution of tobacco products in order to protect public health. To better inform FDA’s regulatory authorities, the NIH and FDA formed an interagency partnership to foster tobacco regulatory research, capitalizing on NIH’s infrastructure to support tobacco-related research and funding from FDA.
|
|
Tobacco Use Supplement to the Current Population Survey
|
Health Survey
|
CDC, FDA
|
NCI, NIMHD
|
The Tobacco Use Supplement to the Current Population Survey (TUS-CPS) is an NCI-sponsored survey of tobacco use that has been administered as part of the US Census Bureau's Current Population Survey approximately every 3-4 years since 1992-93.
|
|
Toxicology in the 21st Century (Tox 21)
|
Resource Development
|
FDA
|
NCATS, NIEHS
|
The Toxicology in the 21st Century (Tox21) program is a federal collaboration among NIH's National Center for Advancing Translational Science (NCATS) and the National Toxicology Program (now called Division of Translational Toxicology, NIEHS; the Environmental Protection Agency; and the Food and Drug Administration. Tox21 researchers aim to develop better toxicity assessment methods to quickly and efficiently test whether certain chemical compounds have the potential to disrupt processes in the human body that may lead to negative health effects.
|
|
Toxin Working Group of the Intragovernmental Select Agents and Toxins Technical Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
The workgroup holds biweekly meetings to discuss the following: point of regulation of select toxins (Botulinum neurotoxins, Staphylococcal enterotoxins, Abrin, Ricin, Conotoxins, Saxitoxin, Tetrodotoxin, Diacetoxyscirpenol, T-2 toxin), natural environment, toxin exclusion limits, space decontamination, and potential updates to the Centers for Disease Control and Prevention (CDC) manual “Biosafety in Microbiological and Biomedical Laboratories.”
|
|
Toxins Assessment Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ASPR, CDC, FDA
|
NIAID
|
Biological (not engineered) toxins with specific effects on the nervous system, focusing on neurotoxins, applications in medical research and historical consideration as bioweapons
|
|
Training Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ
|
CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/ORIP, OD/OER
|
The Training Advisory Committee (TAC) advises on programmatic, review, and management issues related to extramural research training, research education, career development and diversity programs and the Loan Repayment Programs (LRP), and evaluation of these programs. TAC provides a trans-NIH forum to identify and discuss issues related to these programs and recommend solutions.
|